Format

Send to

Choose Destination
N Engl J Med. 2018 Jan 11;378(2):192-193. doi: 10.1056/NEJMe1714580.

Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer.

Author information

1
From the Department of Medicine, Royal Marsden Hospital, and the Section of Genomic Medicine, National Heart and Lung Institute, Imperial College, London.
PMID:
29320658
DOI:
10.1056/NEJMe1714580
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon Icon for Spiral, Imperial College Digital Repository
Loading ...
Support Center